Alimta

... Durant Democrat Local News World News Letters to the Editor Lifestyles Announcements Opinion For a more detailed search click here.

Area linksDurant Area Church DirectoryDurant Area Chamber of Commerce Southeastern Oklahoma State UniversityMedical Center of Southeastern OklahomaOrder Photosmore to come JOBS CARS HOMES ALL ADS Search Classifieds Will the steroid scandal have a negative impact on the current Major League baseball season?

Yes No Not Sure In this section Adobe Buys Macromedia in $3.4B Stock DealCoke: Justice Dept.

Ends 2-Year-Old ProbeStocks Fluctuate on Economic WorriesBank of America Profit Up on AcquisitionEli Lilly Profit Up As Zyprexa Sales ErodeMartha Stewart Gets Own Channel on Sirius3M Posts Higher 1Q Profit but Stock FallsOil Prices Cling Near $50 a Barrel LevelHasbro Reports 1Q Loss on Higher CostsWorldCom's Ebbers Seeks New Trial Eli Lilly Profit Up As Zyprexa Sales Erode By KEN KUSMER INDIANAPOLIS, Ind.

- Eli Lilly & Co.

on Monday said its profits climbed during the first quarter despite eroding sales of its anti-psychosis drug Zyprexa and attention deficit disorders treatment Strattera, which has a new warning about side effects.Lilly also said second quarter earnings would fall short of current Wall Street estimates, but it expected to meet investors' expectations for the full year.Lilly earned $736.6 million, or 68 cents per share, in the January-March period, up from $400.4 million, or 37 cents per share, during the same period ...

... FOXNews.com - Business - Eli Lilly Earnings Top Estimates, Sales Outlook Disappoints SEARCH E-MAIL STORY PRINTER FRIENDLY FOXFAN CENTRAL Eli Lilly Earnings Top Estimates, Sales Outlook Disappoints Monday, April 18, 2005 The drugmaker Eli Lilly & Co.

(LLY) on Monday said its profit climbed in the first quarter, beating expectations on strong sales of newer products, but said its profit for the second quarter would be below current Wall Street estimates.

Its shares rose 6 cents to $58.13 on the New York Stock Exchange (search).

They have traded in a range of $50.34 and $76.95 over the past 52 weeks.

Earnings rose to $736.6 million, or 68 cents per share, in the January-March period from $400.4 million, or 37 cents per share, a year ago.

Year-ago figures reflect acquired in-process research and development expenses of $362.3 million.

Excluding that expense, and assuming the expensing of stock options, net income for the 2004 quarter was $671.4 million, or 62 cents per share.

The result for the latest quarter topped the company's previous estimate for earnings of 65 cents to 67 cents per share and the consensus estimate of analysts surveyed by Thomson Financial, who were looking for earnings of 66 cents.

Sales rose 4 percent to $3.5 billion from $3.38 billion, and would have risen about 7 percent if not for roughly $130 million of reductions in wholesaler inventory levels during the quarter as a result of the company's recent restructur...

... Forbes.com: Update 4: Eli Lilly 1Q Profit Up Despite Weak Sales '); } if( partner == 'netscape' ) { document.write(''); } if (document.cookie.indexOf('partner_session=earthlink') !

= -1) { document.write(''); } if (document.cookie.indexOf('partner_session=msnbc') !

= -1) { var _rsCI='us-forbes'; var _rsCG='msnbc_hat_test'; var _rsDT=1; var _rsSI=escape(window.location); var _rsLP=location.protocol.indexOf('https')=4) { var _rsRD=(new Date()).getTime(); var _rsSE=1; var _rsSV=''; var _rsSM=1.0; _rsCL=''; } else { _rsCL=''; } //document.write(_rsCL); document.write(''); } if (document.cookie.indexOf('partner_session=compuserve') !

= -1) { document.write(''); } // -> Jump | Free Trial Issue Search Quote Select Section Home Investment Newsletters Polls & Discussions Premium Tools Special Reports Video & Audio Watchlist IT Research Library IT Product & Service Search Business -Manufacturing -Technology -Commerce -Services -Energy -Healthcare -Small Business Technology -E-Business -Enterprise Tech -Infoimaging -Intelligent Infrastructure -Personal Tech -Sciences & Medicine -Wireless -CIO Network Markets -Equities -Economy -Commodities -Bonds -Emerging Markets -Currencies Work -Careers -Compensation -Entrepreneurs -Management Lists -Companies -Forbes 500s -Forbes Global 500 -200 Best Small Cos.

-400 Best Big Cos.

-Largest Pri...